InMed Pharmaceuticals Inc.
Pharmaceutical company · Vancouver, British Columbia, Canada · Nasdaq: INM
InMed Pharmaceuticals Inc. is a pharmaceutical company headquartered in Vancouver, British Columbia, Canada. Its shares trade on Nasdaq under the ticker INM. It has reported private securities offerings to the US SEC, most recently $6 million sold in a notice filed in 2022.
InMed Pharmaceuticals at a glance
What does InMed Pharmaceuticals do?
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $6 million sold (2022).
Frequently asked questions about InMed Pharmaceuticals
Where is InMed Pharmaceuticals headquartered?
InMed Pharmaceuticals Inc. is headquartered in Vancouver, British Columbia, Canada.
What does InMed Pharmaceuticals do?
InMed Pharmaceuticals Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is InMed Pharmaceuticals a public company?
Yes. InMed Pharmaceuticals Inc. trades on Nasdaq under the ticker INM.
Similar companies
- AbCellera Biologics Inc.Vancouver, British Columbia, Canada
- Eupraxia Pharmaceuticals Inc.Vancouver, British Columbia, Canada
- Clearmind Medicine Inc.Vancouver, British Columbia, Canada
- Aurinia Pharmaceuticals Inc.Edmonton, Alberta, Canada
- Medicenna Therapeutics Corp.Toronto, Ontario, Canada
- Satellos Bioscience Inc.Markham, Ontario, Canada
- Edesa Biotech, Inc.Markham, Ontario, Canada
- Lexaria Bioscience Corp.Kelowna, British Columbia, Canada
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.